Literature DB >> 33394366

Radiomic features for prostate cancer grade detection through formal verification.

Antonella Santone1, Maria Chiara Brunese1, Federico Donnarumma1, Pasquale Guerriero1, Francesco Mercaldo2, Alfonso Reginelli3, Vittorio Miele4, Andrea Giovagnoni5, Luca Brunese1.   

Abstract

AIM: Prostate cancer represents the most common cancer afflicting men. It may be asymptomatic at the early stage. In this paper, we propose a methodology aimed to detect the prostate cancer grade by computing non-invasive shape-based radiomic features directly from magnetic resonance images.
MATERIALS AND METHODS: We use a freely available dataset composed by coronal magnetic resonance images belonging to 112 patients. We represent magnetic resonance slices in terms of formal model, and we exploit model checking to check whether a set of properties (formulated with the support of pathologists and radiologists) is verified on the formal model. Each property is related to a different cancer grade with the aim to cover all the cancer grade groups.
RESULTS: An average specificity equal to 0.97 and an average sensitivity equal to 1 have been obtained with our methodology.
CONCLUSION: The experimental analysis demonstrates the effectiveness of radiomics and formal verification for Gleason grade group detection from magnetic resonance.

Entities:  

Keywords:  Formal methods; Gleason grade group; Model checking; Prostate; Radiomics

Year:  2021        PMID: 33394366     DOI: 10.1007/s11547-020-01314-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  21 in total

1.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

Review 2.  Role of Texture Analysis in Oropharyngeal Carcinoma: A Systematic Review of the Literature.

Authors:  Eleonora Bicci; Cosimo Nardi; Leonardo Calamandrei; Michele Pietragalla; Edoardo Cavigli; Francesco Mungai; Luigi Bonasera; Vittorio Miele
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

3.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 4.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

5.  Early Diagnosis of Liver Metastases from Colorectal Cancer through CT Radiomics and Formal Methods: A Pilot Study.

Authors:  Aldo Rocca; Maria Chiara Brunese; Antonella Santone; Pasquale Avella; Paolo Bianco; Andrea Scacchi; Mariano Scaglione; Fabio Bellifemine; Roberta Danzi; Giulia Varriano; Gianfranco Vallone; Fulvio Calise; Luca Brunese
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

6.  Structured reporting of computed tomography in the staging of colon cancer: a Delphi consensus proposal.

Authors:  Vincenza Granata; Lorenzo Faggioni; Roberta Grassi; Roberta Fusco; Alfonso Reginelli; Daniela Rega; Nicola Maggialetti; Duccio Buccicardi; Barbara Frittoli; Marco Rengo; Chandra Bortolotto; Roberto Prost; Giorgia Viola Lacasella; Marco Montella; Eleonora Ciaghi; Francesco Bellifemine; Federica De Muzio; Giulia Grazzini; Massimo De Filippo; Salvatore Cappabianca; Andrea Laghi; Roberto Grassi; Luca Brunese; Emanuele Neri; Vittorio Miele; Francesca Coppola
Journal:  Radiol Med       Date:  2021-11-06       Impact factor: 3.469

7.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

Review 8.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

9.  Radiomics in hepatic metastasis by colorectal cancer.

Authors:  Vincenza Granata; Roberta Fusco; Maria Luisa Barretta; Carmine Picone; Antonio Avallone; Andrea Belli; Renato Patrone; Marilina Ferrante; Diletta Cozzi; Roberta Grassi; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-06-02       Impact factor: 2.965

10.  Radiomic and Artificial Intelligence Analysis with Textural Metrics Extracted by Contrast-Enhanced Mammography and Dynamic Contrast Magnetic Resonance Imaging to Detect Breast Malignant Lesions.

Authors:  Roberta Fusco; Elio Di Bernardo; Adele Piccirillo; Maria Rosaria Rubulotta; Teresa Petrosino; Maria Luisa Barretta; Mauro Mattace Raso; Paolo Vallone; Concetta Raiano; Raimondo Di Giacomo; Claudio Siani; Franca Avino; Giosuè Scognamiglio; Maurizio Di Bonito; Vincenza Granata; Antonella Petrillo
Journal:  Curr Oncol       Date:  2022-03-13       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.